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Abstract: In this study 50 chronic renal failure
patients were tested for blood ABO groups and for
the presence of lymphocytotoxic antibodies against a
panel of 20 donor lymphocytes (of known HLA
types) using microcytotoxicity assay. The influence
of other factors affecting sensitization, such as
number of blood transfusions, pregnancies and
previous graft rejections were analyzed too. The
results showed that41.2 % of blood group 0 patients,
61.1 % of group A I, 90% of group B, and 80% of
group A IB are sensitized (PRA> 10%).
These results pointed to higher incidence of
sensitization in patients with blood groups Band
A IB as compared to groups A I and 0 .
Our data suggest an impact of the ABO system on the
sensitization phenomenon.
Introduction
The increased population of sensitized uremic
patients, i.e., pauents having lymphocytotoxic anti-
bodies waiting for kidney grafts is one of the critical
problems in organ transplantation in terms of
magnitude and impact [13].
Sensitization occurs after exposure to foreign HLA
antigens associated with blood transfusion, preg-
nancies, or previous allograft rejections [12J.
Young and Jordan 1992, suggested that chronic
infections might have also a role III sensitization.
The role of ABO blood groups In kidney graft
survival had been documented in a number of studies,
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[3] this role might be played at least partially through
modulating the tendency for the development of
lymphocytotoxic antibodies.
Indeed, Klouda and Bradley in 1985, suggested that
the ABO system could playa role in the development
of cytotoxic antibodies.
In the present study, we analyzed the possible
influence of ABO blood groups upon the incidence
and the degree of sensitization in fifty potential renal
transplant recipient (chronic renal failure patients) in
terms of lymphocytotoxic antibody production.
Materials and methods
Patients: 50 chronic renal failure patients on chronic
dialysis at Bab EL-Shaereya University Hospital and
Nile International Kidney Center.
Lymphocyte donors: 20 potential kidney Donors
attending Tissue Typing Laboratories at Ain-Sharns
University Specialized Hospital, National Institute of
Nephrology and Urology and Cairo Medical Center.
Data obtained from patients files:
• Number of pregnancies, number of blood trans-
fusions and number of graft rejections.
• Results of HBs Ag, HCY Ab, and HIV Ab.
Laboratory Techniques
Patients:
I. ABO blood groups (Forward / Reverse).
2. Panel reactivity determination (PRA %)using
lymphocyte microcytotoxicity test as described by
Khalil & Terasaki 1991. Lymphocyte donors:
HLA typing (Class I and II) using lymphocyte
microcytotoxicity test.
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• 10% of cases were positive for Hbs Ag.
• 8.6 % of cases were positive for HeV Ab.
• None of our patients was positive for HIV Ab.
Fig. 1. Distribution of female patients according to parity and
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Distribution of patients according to number of blood
transfusions and blood groups (figure 2)
Fig. 2. Distribution of patient, according 10 number of blood
transfusions and blood group" (with reference to the 'k of
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Distribution of patients according to different blood
groups (figure 3)
Fig. 3. Distribution of patient, according 10 dillerent blood group"
(With reference In their ,..:\..:,)
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Distribution of sensitization among different blood
groups (figure 4)
Fig. 4. Distribution of sensitization among different blood groups
(with reference to PRA 'k)
Discussion
The ABO system was discovered by Landsriener. and
later was found to be determined by a group of
glycoprotein antigens 191. It had been considered as a
barrier to be respected the same way the HLA barrier
is respected in transplantation procedures.
It had been suggested that the ABO system could be
included among factor" that influence the tendency
for development of lymphocytotoxic antibodies 171.
In the present work, the incidence of cytotoxic anti-
bodies against a panel of 20 donor lymphocytes of
known HLA types, was studied in 50 chronic renal
failure patients (27 males and 23 females) and the
impact of ABO groups on this phenomenon was
analysed.
It was found that 62l)( (31) of the studied patients
had PRA levels> 10%. A slightly lower incidence
was found when we reviewed results obtained from
other larger studies as those by Rulfoux et al 1985,
who found that 61 ~ of 2800 dialysis patients at Saint
LOUIS Hospital, Paris, France were sensiti/cd and
among them ~42 patients (21 (h ) were hyper
immunized with PRA > 75o/r.
Chronic infections were listed by Young and Jordan
1992, among the causes of sensitization, so we
assumed that the higher prevalence of HCY ruteetion
among the studied patients - 96(h in the present study
compared to a range or 6(h to 41.7 (h prevalence
reponed by Manfro et al 1995 may also he partially
responsible Ior this high incidence of scnsui/ation.
The influence of parity status on scnsiu/uuon has
been demonstrated by Hendriks ct al 1985. who
reported that 24o/r of all highly sensitized patients on
the Eurotransplant Waiting list In June, 1985 were
multiparous women confirrrung the importance or
previous pregnancies ,IS a risk factor for the develop-
ment of broadly reactive cytotoxic antibodies.
apparently due to rrnrnumzauon to the spouse's HLA-
haplotype inherited in the fetus during previous
pregnancies [11 J.
In the present study 5 out of 7 nulliparous patients
01.4%) had PRA > 10% compared to 7 out of 7
(100%) grand multiparous patients.
The influence of blood transfusion had been stressed
upon by Cicciarelli 1990, who pointed out that the
development of PRA increases with challenge by
blood transfusion, possibly due to active immuno-
logic suppression, clonal deletion, clonal anergy, Ol
exclusion of immunologic responders [15].
Transfusing HLA-matched blood, specifically from
the prospective kidney donor. will decrease the
meidenee of sensitisation.
Unfortunately, all of our studied transfused patients
had received transfusions from random donors, and
this may explain the near double fold incidence of
sensitizauon among patients who received more than
live transfusions (84%), when compared to only 44%
of those who received five blood transfusions or less.
Concernina the influence of Iailcd previous
allografts a sigmficant increase in the prevalence of
PRA in renal transplant recipients 28.57% hefore the
first uurisptant to 709( after rejection of the first
allograft was reported. In the present study, two of
our pal lent" each had previously rejected two renal
allopralls and u third patient rejected one graft, and
allot" tnc three patients consistently, had PI<A > S()~,(,
urcspccuve ol AHO blood group. number ot preg -
nartcics or blood transfusion
In attempt to determine whether sensitization rOl
kidney allograft is influenced by ABO blood groups
or the reerpient. Klouda and Bradley I%5, reviewed
a totul of 2412 pauents, \..alting lor il kidney
allograft, they found that among non-sensitized
patients there was excess of group U over group A. a
result suggc.-.tlng that group A paucnts may he more
likely to produce PRA than their group 0
-ountcrparts. und that the ABO ~\ stem could playa
roll' III the development of cytoiox ic anti hod res,
In the present study 7 out of 17 blood group 0
paucnts (41 :!c,f,) had PRA > ICY~ as compared to II
out of Ih blood group A patients (61.1 (*) We also
found thai 9 out of 10 (90(Yr,) blood group B patients
had the highest sensill/ation rate among different
blood group!>, followed by blood group A IB where 4
out of 5 patients (80%) were sensitized
Although, In the present study blood group B patients
had the highest incidence of sensitization, blood
group A IB patients had the highest incidence of
being highly sensitized with PRA> 50% where 3 out
of 5 patients (60%) were highly sensitized followed
by blood group B. where 4 out of 10 patients were
highly sensitized, and lastly blood group 0 where I
out of 17 patients (5.9%) had PRA > 50%. On the
other hand, none of blood group A patients in the
present study reached such a high PRA percentage.
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The discrepancy between the incidence of sensitr-
zation and its degree among various blood groups
may be attributed to the multiplicity of risk factors.
Generally B and AlB groups attained the highest
incidence and degree of sensitization as compared to
groups 0 and A.
The higher incidence of sensitization found in the
present study among blood group B patients might be
at least partially responsible for the poor graft
survival rates among blood group B patients and
similarly the better graft survival rates among blood
group 0 patients as reported b) Hassan 1994. Again,
the longest renal waiting times. for every racial
groups (Whites, Blacks and others) studied by Ellison
et al 1993, in blood group B patients may be
accounted for by the higher incidence of sensitization
among them.
So, we suggest that certain ABO blood groups are
associated with lower tendency for sensitization and
les,", broadly reactive antibodies (lower PRA %) as
blood group 0 followed by group A, whereas blood
groups B and A IBare associated with higher
tendency for sensitization and with more broad panel
reacuvity (higher PRA CiC).
If such an association IS confirmed by larger studies
the chances of sensitization in a given prospective
kidney transplant recipient could be predicted
allowmg hetter tailoring of immunosuppressive
protocols.
Conclusion
We can conclude that ABO blood groups apparently
have some kind of influence upon the sensinzatton
phenomenon. The tendency for sensitization ill
general and being highly sensitized in particular IS
different alllong patients of different blood groups as
evidenced hy the highest incidence and degree 0:
scnsruzauon in blood groups B and AlB patients.
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